What is the long-term trend for Xtant Medical Holdings's cash and cash equivalents, end of period?

Over 5 years (2020 to 2025), Xtant Medical Holdings's cash and cash equivalents, end of period has grown at a 49.2% compound annual growth rate (CAGR), from $2.34M to $17.33M.

Xtant Medical Holdings XTNT Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66PSX

$5.15B+246%

3MMMM

$3.73B-41.1%

eBayEBAY

$4.23B+1.9%

American Financial GroupAFG

$1.35B+6.0%

Erie Indemnity CompanyERIE

$268.62M+3.2%

W.R. BerkleyWRB

$2.28B+32.6%

Other financials

Income statement

See full

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

See full

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation

See full

Market cap$59.05M-32.5%

Enterprise value$61.89M-41.5%

P/E32.3×—

P/S0.5×-0.2×

Profitability

See full

Gross margin62.3%+4.2pp

Operating margin4.8%+2.8pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

See full

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xtant Medical Holdings's cash and cash equivalents, end of period?: Xtant Medical Holdings (XTNT) reported cash and cash equivalents, end of period of $12.16M in Q1 2026.
How has Xtant Medical Holdings's cash and cash equivalents, end of period changed year-over-year?: Xtant Medical Holdings's cash and cash equivalents, end of period increased by 123.7% year-over-year, from $5.44M to $12.16M.
What is the long-term trend for Xtant Medical Holdings's cash and cash equivalents, end of period?: Over 5 years (2020 to 2025), Xtant Medical Holdings's cash and cash equivalents, end of period has grown at a 49.2% compound annual growth rate (CAGR), from $2.34M to $17.33M.